传记

伊岚L. Hollin, 博士学位, is currently an assistant professor in the Department of Health Services Administration and Policy within the College of Public Health at Temple University. Dr. Hollin joined the HSAP faculty having completed a post-doctoral fellowship with the Leonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California (USC) and the National Pharmaceutical Council (NPC). Dr. Hollin earned her 博士学位 in health economics and policy from the Johns Hopkins Bloomberg School of Public Health and her MPH in effectiveness and outcomes research from the Columbia University Mailman School of Public Health.

Dr. Hollin’s research interests include patient-centered decision-making, including patient and caregiver preferences and outcomes research, the value of health technologies including pharmaceuticals and health information technology, and the impact of insurance policy on access among pediatric populations. Dr. Hollin is especially interested in research that facilitates better healthcare for complex patient populations, such as those with rare diseases and children with special healthcare needs. She is also interested in bridging the gap between health research and policy analysis and is passionate about incorporating the patient perspective in all aspects of healthcare, research and policy.

教育

  • 博士学位, Health Economics and Policy, Johns Hopkins University School of Public Health
  • MPH, Columbia University
  • BA, American Studies; International Studies, Brandeis University

Curriculum Vitae 

课程

数量

名字

水平

HPM 8008

Health Economics

研究生

Selected Publications

  • 直到J.A.v.皮尔斯,A.Ozdemir, S., Hollin,我.L., Peay H.L.吴,A.W., Ostermann, J.成交,K., & 克雷格,B.M. (2024). Role Preferences in Medical Decision Making: Relevance and Implications for Health Preference 研究. 病人, 17(1), pp. 3-12. 新西兰. doi: 10.1007/s40271-023-00649-4

  • 在香港,我., Hollin,我.L., & 埃里森,T.A. (2023). Economic Evaluation in Kidney Transplantation: A Scoping Review and Novel PESTLE Stakeholder Gaps Analysis. Transplant Proc, 55(10), pp. 2419-2428. 美国. doi: 10.1016/j.transproceed.2023.10.002

  • Hollin,我.L. & 球,我.G. (2022). Does price disclosure in pharmaceutical advertising result in price transparency? Evidence from a randomized experiment. Explor Res Clin Soc Pharm, 8, p. 100180. 美国. doi: 10.1016/j.rcsop.2022.100180

  • Hollin,我.L.帕斯卡特,J.舒斯特,A.L.R., Crossnohere, N.L., & 桥梁、J.F.P. (2022). Best-Worst Scaling and the Prioritization of Objects in Health: A Systematic Review. Pharmacoeconomics, 40(9), pp. 883-899. 新西兰. doi: 10.1007/s40273-022-01167-1

  • 球,我.G. & Hollin,我.L. (2022). Attention to price disclosures in direct-to-consumer prescription drug advertising and the impact on drug perceptions. Res Social Adm Pharm, 18(8), pp. 3402-3413. 美国. doi: 10.1016/j.sapharm.2021.11.003

  • Nossov,年代.B., Hollin,我.L.菲利普斯,J。., & 富兰克林,C.C. (2022). Proximal Femoral Focal Deficiency/Congenital Femoral Deficiency: Evaluation and Management. J Am Acad Orthop Surg, 30(13), pp. e899-e910. 美国. doi: 10.5435/JAAOS-D-21-01186

  • 鲈鱼,年代.B., Hollin,我.L.凯利,P.J.阿尔哈吉,M.D’avanzo, P.毛雷尔,L., Gillespie, A.Schatell, D., & 加德纳,H. (2022). Perceptions of Live Donor Kidney Transplantation Using Segmentation Analysis and Perceptual Mapping to Understand Differences by Self-Reported Health Status in People on Dialysis. Frontiers in Communication, 6, p. 785186. doi: 10.3389 / fcomm.2021.785186

  • Hollin,我.L.博尼拉,B.巴格利,A., & 塔克,C.A. (2022). Social and environmental determinants of health among children with long-term movement impairment. Front Rehabil Sci, 3, p. 831070. 瑞士. doi: 10.3389 / fresc.2022.831070

  • Hollin,我.L.杨森,E.凯利,M.A., & 桥梁、J.F.P. (2021). Do people have differing motivations for participating in a stated-preference study? Results from a latent-class analysis. BMC Med Inform Decis Mak, 21(1), p. 44. 英格兰. doi: 10.1186/s12911-021-01412-1

  • 约翰逊,K., Hollin,我.帕伦坡,A.斯皮策,J., & 萨沃,D. (2020). An Ecologic Analysis of Comorbidities in 病人s with COVID-19 in Philadelphia and New York City. 为什么, 1(3), pp. 85-92. doi: 10.15367/ch.v1i3.407

  • Hollin,我.L.克雷格,B.M.海岸,J., Beusterien, K.C., DiSantostefano, R., & Peay H. (2020). Reporting Formative Qualitative 研究 to Support the Development of Quantitative Preference Study Protocols and Corresponding Survey Instruments: Guidelines for Authors and Reviewers. 病人, 13(1), pp. 121-136. 新西兰. doi: 10.1007/s40271-019-00401-x

  • Hollin,我.L., González, J.M.,但是,L., Ciarametaro, M., & 杜布瓦,R.W. (2020). Do 病人 Preferences Align With Value Frameworks? A Discrete-Choice Experiment of 病人s With Breast Cancer. MDM Policy Pract, 5(1), p. 2381468320928012. 美国. doi: 10.1177/2381468320928012

  • Hollin,我.L., Donaldson, S.H.罗曼,C., Aliaj, E.里瓦,D.博伊尔,M., & Borowitz D. (2019). Beyond the expected: Identifying broad research priorities of researchers and the cystic fibrosis community. J囊肿纤维, 18(3), pp. 375-377. 荷兰. doi: 10.1016/j.jcf.2018.11.010

  • Hollin,我.L.迪莫克,A.E.f.布里奇斯.F.p.丹诺夫,S.K., & 数据,R. (2019). Collecting patient preference information using a Clinical Data 研究 Network: demonstrating feasibility with idiopathic pulmonary fibrosis. 病人 Prefer Adherence, 13, pp. 795-804. 新西兰. doi: 10.2147 / PPA.S201632